Caricamento...
Metastatic breast cancer: Endocrine therapy landscape reshaped
Endocrine therapy (ET) of hormone receptor (HR)-positive and human epidermal growth factor receptor 2-(HER2)-negative metastatic breast cancer (MBC) historically focused on estrogen deprivation and antagonism. The identification of several intracellular pathways promoting resistance to antiestrogen...
Salvato in:
| Pubblicato in: | Avicenna J Med |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Medknow Publications & Media Pvt Ltd
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5655644/ https://ncbi.nlm.nih.gov/pubmed/29119080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ajm.AJM_20_17 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|